Nikesh R Shrestha1, Prahlad Karki2, Rajan Mahto2, Keshar Gurung1, Naveen Pandey2, Krishna Agrawal2, Martina Rothenbühler3, Philip Urban4, Peter Jüni5, Thomas Pilgrim6. 1. Department of Cardiology, Neuro Cardio and Multispeciality Hospital, Biratnagar, Nepal. 2. Department of Internal Medicine, B. P. Koirala Institute of Health Sciences, Dharan, Nepal. 3. Clinical Trials Unit, University of Bern, Bern, Switzerland. 4. Department of Cardiology, Hôpital de la Tour, Geneva, Switzerland. 5. Applied Health Research Centre, Li Ka Shing Knowledge Institute of St. Michael's Hospital, and Department of Medicine, University of Toronto, Toronto, Ontario, Canada. 6. Department of Cardiology, Bern University Hospital, Bern, Switzerland.
Abstract
IMPORTANCE: Although rheumatic heart disease has been nearly eradicated in high-income countries, 3 in 4 children grow up in parts of the world where it is still endemic. OBJECTIVES: To determine the prevalence of clinically silent and manifest rheumatic heart disease as a function of age, sex, and socioeconomic status and to estimate age-specific incidence. DESIGN, SETTING, AND PARTICIPANTS: In this school-based cross-sectional study with cluster sampling, 26 schools in the Sunsari district in Eastern Nepal with 5467 eligible children 5 to 15 years of age were randomly selected from 595 registered schools. After exclusion of 289 children, 5178 children were enrolled in the present study from December 12, 2012, through September 12, 2014. Data analysis was performed from October 1, 2014, to April 15, 2015. EXPOSURES: Demographic and socioeconomic characteristics were acquired in a standardized interview by means of a questionnaire customized to the age of the children. A focused medical history was followed by a brief physical examination. Cardiac auscultation and transthoracic echocardiography were performed by 2 independent physicians. MAIN OUTCOMES AND MEASURES: Rheumatic heart disease according to the World Heart Federation criteria. RESULTS: The median age of the 5178 children enrolled in the study was 10 years (interquartile range, 8-13 years), and 2503 (48.3%) were female. The prevalence of borderline or definite rheumatic heart disease was 10.2 (95% CI, 7.5-13.0) per 1000 children and increased with advancing age from 5.5 (95% CI, 3.5-7.5) per 1000 children 5 years of age to 16.0 (95% CI, 14.9-17.0) in children 15 years of age, whereas the mean incidence remained stable at 1.1 per 1000 children per year. Children with rheumatic heart disease were older than children without rheumatic heart disease (median age [interquartile range], 11 [9-14] years vs 10 [8-13] years; P = .03), more commonly female (34 [64.2%] vs 2469 [48.2%]; P = .02), and more frequently went to governmental schools (40 [75.5%] vs 2792 [54.5%]; P = .002). Silent disease (n = 44) was 5 times more common than manifest disease (n = 9). CONCLUSIONS AND RELEVANCE: Rheumatic heart disease affects 1 in 100 schoolchildren in Eastern Nepal, is primarily clinically silent, and may be more common among girls. The overall prevalence and the ratio of manifest to subclinical disease increase with advancing age, whereas the incidence remains stable at 1.1 per 1000 children per year. Early detection of silent disease may help prevent progression to severe valvular damage.
IMPORTANCE: Although rheumatic heart disease has been nearly eradicated in high-income countries, 3 in 4 children grow up in parts of the world where it is still endemic. OBJECTIVES: To determine the prevalence of clinically silent and manifest rheumatic heart disease as a function of age, sex, and socioeconomic status and to estimate age-specific incidence. DESIGN, SETTING, AND PARTICIPANTS: In this school-based cross-sectional study with cluster sampling, 26 schools in the Sunsari district in Eastern Nepal with 5467 eligible children 5 to 15 years of age were randomly selected from 595 registered schools. After exclusion of 289 children, 5178 children were enrolled in the present study from December 12, 2012, through September 12, 2014. Data analysis was performed from October 1, 2014, to April 15, 2015. EXPOSURES: Demographic and socioeconomic characteristics were acquired in a standardized interview by means of a questionnaire customized to the age of the children. A focused medical history was followed by a brief physical examination. Cardiac auscultation and transthoracic echocardiography were performed by 2 independent physicians. MAIN OUTCOMES AND MEASURES: Rheumatic heart disease according to the World Heart Federation criteria. RESULTS: The median age of the 5178 children enrolled in the study was 10 years (interquartile range, 8-13 years), and 2503 (48.3%) were female. The prevalence of borderline or definite rheumatic heart disease was 10.2 (95% CI, 7.5-13.0) per 1000 children and increased with advancing age from 5.5 (95% CI, 3.5-7.5) per 1000 children 5 years of age to 16.0 (95% CI, 14.9-17.0) in children 15 years of age, whereas the mean incidence remained stable at 1.1 per 1000 children per year. Children with rheumatic heart disease were older than children without rheumatic heart disease (median age [interquartile range], 11 [9-14] years vs 10 [8-13] years; P = .03), more commonly female (34 [64.2%] vs 2469 [48.2%]; P = .02), and more frequently went to governmental schools (40 [75.5%] vs 2792 [54.5%]; P = .002). Silent disease (n = 44) was 5 times more common than manifest disease (n = 9). CONCLUSIONS AND RELEVANCE: Rheumatic heart disease affects 1 in 100 schoolchildren in Eastern Nepal, is primarily clinically silent, and may be more common among girls. The overall prevalence and the ratio of manifest to subclinical disease increase with advancing age, whereas the incidence remains stable at 1.1 per 1000 children per year. Early detection of silent disease may help prevent progression to severe valvular damage.
Authors: Gene Bukhman; Ana O Mocumbi; Rifat Atun; Anne E Becker; Zulfiqar Bhutta; Agnes Binagwaho; Chelsea Clinton; Matthew M Coates; Katie Dain; Majid Ezzati; Gary Gottlieb; Indrani Gupta; Neil Gupta; Adnan A Hyder; Yogesh Jain; Margaret E Kruk; Julie Makani; Andrew Marx; J Jaime Miranda; Ole F Norheim; Rachel Nugent; Nobhojit Roy; Cristina Stefan; Lee Wallis; Bongani Mayosi Journal: Lancet Date: 2020-09-14 Impact factor: 79.321
Authors: John Musuku; Joyce C Lungu; Elizabeth Machila; Catherine Jones; Laurence Colin; Sherri Schwaninger; Patrick Musonda; Brigitta Tadmor; Jonathan M Spector; Mark E Engel; Liesl J Zühlke Journal: BMC Infect Dis Date: 2017-07-06 Impact factor: 3.090
Authors: Jean Jacques Noubiap; Valirie N Agbor; Jean Joel Bigna; Arnaud D Kaze; Ulrich Flore Nyaga; Bongani M Mayosi Journal: Sci Rep Date: 2019-11-19 Impact factor: 4.379
Authors: John Musuku; Mark E Engel; Patrick Musonda; Joyce Chipili Lungu; Elizabeth Machila; Sherri Schwaninger; Agnes Mtaja; Evans Mulendele; Dorothy Kavindele; Jonathan Spector; Brigitta Tadmor; Marcelo M Gutierrez; Joris Van Dam; Laurence Colin; Aidan Long; Mark C Fishman; Bongani M Mayosi; Liesl J Zühlke Journal: BMC Cardiovasc Disord Date: 2018-07-03 Impact factor: 2.298